Contemporary clinical trials · 2026
Actívatexto: Advancing smoking cessation and physical activity among Latino adults. Study protocol for a randomized clinical trial.
СтатьяНазвание и аннотация: Перевод пока не подготовлен
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Ramos Santiago Jeffrey W, Orfin Rafael H, Lara Daimarelys, Uceda Victoria, Hurtado-de-Mendoza Alejandra, Chávez-Iñiguez Arlette, Fuller Daniel, Bermúdez Diana, Marquez David X, Ossip Deborah J, Li Dongmei, DeJesus Elisa, Vásquez Elizabeth, Carter-Bawa Lisa, Yousefi-Nooraie Reza, McIntosh Scott, Cupertino Ana Paula, Cartujano-Barrera Francisco
Аннотация
INTRODUCTION: Latinos, the largest minority population in the U.S., experience significant tobacco-related health disparities. Prior work by our team led to the development of Decídetexto, a culturally accommodated text messaging smoking cessation intervention that demonstrated efficacy in a randomized controlled trial (RCT). However, most participants did not meet recommended levels of physical activity [at least 150 min of moderate to vigorous physical activity (MVPA) per week], and the intervention did not leverage its potential benefits for smoking cessation, despite evidence suggesting that MVPA may enhance cessation rates.
OBJECTIVES: To describe the methodology of a randomized clinical trial evaluating the efficacy of Actívatexto, a culturally accommodated mobile health intervention that combines smoking cessation and physical activity, versus Decídetexto, a mobile intervention that solely promotes smoking cessation, on smoking abstinence (cotinine-verified 7-day point prevalence abstinence) at Month 6 among Latinos who smoke.
METHODS: Latino adults who smoke and do not meet physical activity guidelines (N = 408) will be randomized to one of two conditions: 1) Actívatexto or 2) Decídetexto. Actívatexto includes four components: 1) a bilingual text messaging program, 2) wearable devices to monitor physical activity, 3) access to nicotine replacement therapy, and 4) a centralized data management dashboard. We will recruit eligible Latino individuals through community and clinic-based approaches. All participants will complete follow-up assessments at Month 3 and Month 6.
DISCUSSION: This study will provide critical evidence on the synergistic effects of integrating physical activity into smoking cessation interventions and inform scalable, culturally responsive strategies to reduce tobacco-related disparities among Latinos.
TRIAL REGISTRATION: ClinicalTrials.gov identifier: NCT06926608.
OBJECTIVES: To describe the methodology of a randomized clinical trial evaluating the efficacy of Actívatexto, a culturally accommodated mobile health intervention that combines smoking cessation and physical activity, versus Decídetexto, a mobile intervention that solely promotes smoking cessation, on smoking abstinence (cotinine-verified 7-day point prevalence abstinence) at Month 6 among Latinos who smoke.
METHODS: Latino adults who smoke and do not meet physical activity guidelines (N = 408) will be randomized to one of two conditions: 1) Actívatexto or 2) Decídetexto. Actívatexto includes four components: 1) a bilingual text messaging program, 2) wearable devices to monitor physical activity, 3) access to nicotine replacement therapy, and 4) a centralized data management dashboard. We will recruit eligible Latino individuals through community and clinic-based approaches. All participants will complete follow-up assessments at Month 3 and Month 6.
DISCUSSION: This study will provide critical evidence on the synergistic effects of integrating physical activity into smoking cessation interventions and inform scalable, culturally responsive strategies to reduce tobacco-related disparities among Latinos.
TRIAL REGISTRATION: ClinicalTrials.gov identifier: NCT06926608.